148 related articles for article (PubMed ID: 7247385)
1. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
Lee FH; Smyth RD; Van Harken DR
Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
[TBL] [Abstract][Full Text] [Related]
3. Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.
Mullany LD; French MA; Nightingale CH; Low HB; Ellison LH; Quintiliani R
Antimicrob Agents Chemother; 1982 Mar; 21(3):416-20. PubMed ID: 7103445
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH
Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ceforanide.
Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
[TBL] [Abstract][Full Text] [Related]
6. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
Gerding DN; Kozak AJ; Peterson LR; Hall WH
Antimicrob Agents Chemother; 1980 Jun; 17(6):1023-9. PubMed ID: 6996611
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
Greenberg RN; Bollinger M
Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
[TBL] [Abstract][Full Text] [Related]
8. Biliary levels of ceforanide.
Kenady DE; Ram MD
Antimicrob Agents Chemother; 1983 May; 23(5):706-9. PubMed ID: 6870219
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents.
Dajani AS; Thirumoorthi MC; Bawdon RE; Buckley JA; Pfeffer M; Van Harken DR; Smyth RD
Antimicrob Agents Chemother; 1982 Feb; 21(2):282-7. PubMed ID: 7073266
[TBL] [Abstract][Full Text] [Related]
10. Ceforanide kinetics in renal insufficiency.
Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
[TBL] [Abstract][Full Text] [Related]
11. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
Randolph JA; Buck RE; Price KE; Leitner F
J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
[TBL] [Abstract][Full Text] [Related]
12. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
Wallace RJ; Martin RR; Quinones FJ; Greenberg SB
Antimicrob Agents Chemother; 1981 Nov; 20(5):648-52. PubMed ID: 7034641
[TBL] [Abstract][Full Text] [Related]
13. Ceforanide kinetics.
Estey EH; Weaver SS; LeBlanc BM; Brown N; Ho DH; Bodey GP
Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
[TBL] [Abstract][Full Text] [Related]
14. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
Ratzan KR; Baker HB; Lauredo I
Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
[TBL] [Abstract][Full Text] [Related]
15. Failure of probenecid to alter the pharmacokinetics of ceforanide.
Jovanovich JF; Saravolatz LD; Burch K; Pohlod DJ
Antimicrob Agents Chemother; 1981 Oct; 20(4):530-2. PubMed ID: 7342878
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
[TBL] [Abstract][Full Text] [Related]
17. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
Barriere SL; Mills J
Pharmacotherapy; 1982; 2(6):322-7. PubMed ID: 6762529
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
Hess JR; Berman SJ; Boughton WH; Sugihara JG; Musgrave JE; Wong EG; Siemsen AM
Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of cefoperazone and cefamandole.
Srinivasan S; Francke EL; Neu HC
Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative ceforanide pharmacokinetics and protein binding.
DiPiro JT; Bayoumi SM; Vallner JJ; Nesbit RR; Gokhale R; Rissing JP
Antimicrob Agents Chemother; 1985 Apr; 27(4):487-90. PubMed ID: 4004190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
